FLGT - Fulgent Genetics EPS beats by $0.89 beats on revenue

Fulgent Genetics (FLGT): Q1 Non-GAAP EPS of $6.59 beats by $0.89; GAAP EPS of $6.52 beats by $0.66.Revenue of $359.43M (+4537.8% Y/Y) beats by $37.92M.2021 outlook:  Raises full year total revenue outlook to $830 million from $800 million, representing growth of 97% year over yearRaises NGS revenue outlook to $100 million from $70 million, representing growth of 174% year over yearExpects GAAP income of approximately $12.00 per share; non-GAAP income of approximately $12.50 per share in 2021Press Release

For further details see:

Fulgent Genetics EPS beats by $0.89, beats on revenue